Improvement of Persistent Detrusor Overactivity through Treatment with a Phytotherapeutic Agent (WSY-1075) after Relief of Bladder Outlet Obstruction

Improvement of Persistent Detrusor Overactivity through Treatment with a Phytotherapeutic Agent (WSY-1075) after Relief of Bladder Outlet Obstruction

Purpose: Many patients with benign prostatic hyperplasia need treatment for remaining storage symptoms after surgery. Therefore, we evaluated the effect of the phytotherapeutic agent WSY-1075 on persistent detrusor overactivity (DO) after the relief of bladder outlet obstruction (BOO). Materials...

Full description

Bibliographic Details
Main Authors:	Su Jin Kim, Seung Hwan Jeon, Eun Bi Kwon, Hyun Cheol Jeong, Sae Woong Choi, Woong Jin Bae, Hyuk Jin Cho, U-Syn Ha, Sung Hoo Hong, Ji Youl Lee, Sung Yeoun Hwang, Sae Woong Kim
Format:	Article
Language:	English
Published:	Korean Society for Sexual Medicine and Andrology 2018-05-01
Series:	The World Journal of Men's Health
Subjects:	Lower urinary tract symptoms Phytotherapy Prostatic hyperplasia Urinary bladder overactive
Online Access:	https://www.wjmh.org/Synapse/Data/PDFData/2074WJMH/wjmh-36-153.pdf

Similar Items

Corrigendum: Improvement of Persistent Detrusor Overactivity through Treatment with a Phytotherapeutic Agent (WSY-1075) after Relief of Bladder Outlet Obstruction
by: Su Jin Kim, et al.
Published: (2018-09-01)

Development of an Improved Animal Model of Overactive Bladder: Transperineal Ligation versus Transperitoneal Ligation in Male Rats
by: Woo Hyun Kim, et al.
Published: (2016-08-01)

Dissimilar Effects of Tolterodine on Detrusor Overactivity in Awake Rats with Chemical Cystitis and Partial Bladder Outlet Obstruction
by: Long-Hu Jin, et al.
Published: (2011-09-01)

Urodynamic Detrusor Overactivity in Patients with Overactive Bladder Symptoms
by: Mohammed A. Al-Ghazo, et al.
Published: (2011-03-01)

Role of Nicotinic Acetylcholine Receptor α3 and α7 Subunits in Detrusor Overactivity Induced by Partial Bladder Outlet Obstruction in Rats
by: Hyo Sin Kim, et al.
Published: (2015-03-01)

A Korean Postmarketing Study Assessing the Effectiveness of OnabotulinumtoxinA for the Treatment of Neurogenic Detrusor Overactivity or Idiopathic Overactive Bladder Using a Validated Patient-Reported Outcome Measure
by: Kwang Jin Ko, et al.
Published: (2019-03-01)

Expression of cannabinoid 1 and, 2 receptors and the effects of cannabinoid 1 and, 2 receptor agonists on detrusor overactivity associated with bladder outlet obstruction in rats
by: Sung Dae Kim, et al.
Published: (2017-12-01)

Phasic or terminal detrusor overactivity in women: age, urodynamic findings and sphincter behavior relationships
by: Françoise A. Valentini, et al.
Published: (2011-12-01)

Abobotulinum - a toxin injection in patients with refractory idiopathic detrusor overactivity: injections in detrusor, trigone and bladder neck or prostatic urethra, versus detrusor - only injections
by: Maryam Emami, et al.

OAB score: A clinical model that predicts the probability of presenting overactive detrusor in the urodynamic study
by: Leandro Cristian Arribillaga, et al.

Botulinum Toxin in Neurogenic Detrusor Overactivity
by: Carlos Arturo Levi D'Ancona, et al.
Published: (2012-09-01)

Near-Normalized Gene Expression Profiles in Bladder With Detrusor Overactivity in Rats With Bladder Outlet Obstruction After Deobstruction
by: Tack Lee, et al.
Published: (2017-12-01)

Clinical Outcome in Male Patients With Detrusor Overactivity With Impaired Contractility
by: Shuo Liu, et al.
Published: (2014-09-01)

The effects of oral administration of the novel muscarinic receptor antagonist DA-8010 on overactive bladder in rat with bladder outlet obstruction
by: Jin Bong Choi, et al.
Published: (2020-04-01)

Predicting Refractory Detrusor Overactivity: Are There any Clues at Diagnosis
by: Kylie J Mansfield, et al.
Published: (2013-12-01)

The Influence of an Overactive Bladder on Falling: A Study of Females Aged 40 and Older in the Community
by: Seung-Jin Moon, et al.
Published: (2011-03-01)

Sphingosine Kinase 1 urothelial expression is increased in patients with neurogenic detrusor overactivity
by: Quentin Ballouhey, et al.
Published: (2015-12-01)

Idiopathic and neurogenic detrusor overactivity: do the different patterns have urodynamic characteristics related to gender or neurological condition?
by: Francoise A. Valentini, et al.
Published: (2013-09-01)

Changes in mast cell infiltration: a possible mechanism in detrusor overactivity induced by visceral hypersensitivity
by: Nian-zhao Zhang, et al.
Published: (2016-04-01)

Detrusor after-contraction: a new insight
by: Françoise A. Valentini, et al.
Published: (2015-06-01)

Efficacy and safety of propiverine and terazosine combination for one year in male patients with luts and detrusor overactivity
by: Nevzat Can Sener, et al.
Published: (2013-07-01)

Development and Changes with Age of Detrusor Overactivity in Spontaneous Hypertensive Rats as Observed by Simultaneous Registrations of Intravesical and Intraabdominal Pressures
by: Long-Hu Jin, et al.
Published: (2011-12-01)

Potential Biomarkers for Diagnosis of Overactive Bladder Patients: Urinary Nerve Growth Factor, Prostaglandin E2, and Adenosine Triphosphate
by: Yoon Seok Suh, et al.
Published: (2017-09-01)

Effectiveness of Retropubic Tension-Free Vaginal Tape and Transobturator Inside-Out Tape Procedures in Women With Overactive Bladder and Stress Urinary Incontinence
by: Ji-Yeon Han, et al.
Published: (2013-09-01)

Detrusor Overactivity May Be a Prognostic Factor for Better Response to Combination Therapy Over Monotherapy in Male Patients With Benign Prostatic Enlargement and Storage Lower Urinary Tract Symptoms
by: Vasileios Sakalis, et al.
Published: (2021-03-01)

Effects of a combination of herbal extracts (modified Ojayeonjonghwan (Wuzi Yanzong wan)) on partial urethral obstruction-induced detrusor overactivity in rats: impact on the nitric oxide pathway and oxidative stress
by: Sangrak Bae, et al.
Published: (2019-03-01)

Urinary Nerve Growth Factor as a Potential Biomarker of Treatment Outcomes in Overactive Bladder Patients
by: Yoon Seok Suh, et al.
Published: (2017-12-01)

Overactive bladder syndrome and bladder wall thickness in patients with obstructive sleep apnea syndrome
by: Zahide Yilmaz, et al.

Friction underwear for ease of pulling down in elderly patients with overactive bladder: A prospective randomized control trial
by: Jae Hyung You, et al.
Published: (2019-05-01)

Evaluation of female overactive bladder using urodynamics: relationship with female voiding dysfunction
by: Kang Jun Cho, et al.
Published: (2015-08-01)

Socioeconomic Costs of Overactive Bladder and Stress Urinary Incontinence in Korea
by: Wooseuk Sung, et al.
Published: (2012-03-01)

Significance of preoperatively observed detrusor overactivity as a predictor of continence status early after robot-assisted radical prostatectomy
by: Akihiro Yanagiuchi, et al.
Published: (2014-12-01)

Intravesical electrical stimulation treatment for overactive bladder: An observational study
by: J. Joshua Yune, et al.
Published: (2018-07-01)

The Prevalence and Therapeutic Effect of Constipation in Pediatric Overactive Bladder
by: Ji Hyun Kim, et al.
Published: (2011-12-01)

Increased Bladder Wall Thickness in Diabetic and Nondiabetic Women With Overactive Bladder
by: Hakkı Uzun, et al.
Published: (2013-06-01)

Diagnostic Tool for Assessing Overactive Bladder Symptoms: Could the International Prostate Symptom Storage Subscore Replace the Overactive Bladder Symptom Score?
by: Ji Sung Shim, et al.
Published: (2016-09-01)

Overactive bladder
by: Anna Zwierzyńska
Published: (2021-07-01)

Impact of overactive bladder on retrograde ejaculation
by: Ahmet Salvarci, et al.

The Impact of Overactive Bladder on Health-Related Quality of Life, Sexual Life and Psychological Health in Korea
by: Eun Sang Yoo, et al.
Published: (2011-09-01)

Korean Version of the Overactive Bladder Symptom Score Questionnaire: Translation and Linguistic Validation
by: Seong Jin Jeong, et al.
Published: (2011-09-01)

Cannot write session to /tmp/vufind_sessions/sess_hrlh04nqeir2cuicoh5ug8f154